Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Rationale The mesotelencephalic dopamine system has been implicated in cognitive processes dependent on an intact prefrontal cortex. Most previous research in humans has focused on dopaminergic agonists and their effects on tasks of working memory.Objectives The present study was designed to investigate the cognitive and subjective effects of two doses (200 mg and 400 mg) of the dopaminergic D(2) receptor antagonist, sulpiride on a broad range of well-validated neuropsychological tasks in a group of 34 young healthy male volunteers.Methods Cognitive tasks were administered to subjects after ingestion of either drug or placebo within a double-blind, placebo-controlled, cross-over design. The cognitive tests included tasks from the Cambridge Neuropsychological Test Automated Battery (CANTAB) and were designed to assess visuospatial recognition memory, planning ability, working memory, strategy learning, sustained attention and attentional set-shifting. In addition, the National Adult Reading Test (NART) was used to assess verbal IQ, and visual analogue scales to assess subjective effects of the drug.Results Subjects on sulpiride were impaired on the tasks of spatial recognition, spatial working memory (sequence generation), planning (one-touch Tower of London) and attentional set-shifting. Only the spatial working memory task demonstrated a dose dependent effect. The impairments were not due to generalised sedative or motoric influences of sulpiride.Conclusions All of the tasks impaired following sulpiride are known to be sensitive to frontal lobe damage and the precise pattern of deficits seen is consistent with the anatomical distribution of central dopamine receptors. The results are discussed with particular reference to their close simulation of the impairments seen in idiopathic Parkinson's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“administration of the D2/D3 receptor antagonist sulpiride to human volunteers impaired extradimensional set-shifting (Mehta et al 1999).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Mehta et al 1999
Citations
Cites
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 26,755
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527 · cited 1×
“Therefore, considering these correlations and the anatomical connections between the frontal lobes and the striatum ( Alexander et al. 1986 ), it is not surprising that the impairments we have demonstrated bear a strong resemblance to the impairments exhibited by patients with PD (Robbins et al. 1998), whose primary p…”
ResultStatistical Methods for Psychology.
Gudgeon, A. C., & Howell, D. C. (1994) · The Statistician · doi:10.2307/2348956 · Cited by 8,278
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725 · cited 1×
“Goldman-Rakic and colleagues have more recently demonstrated that the major class of dopamine D1 receptors, but not the dopamine D2 receptors [see Kebabian and Calne (1979) and Neve and Neve (1997) for explanations of the D1 and D2 receptor families and their respective genetic subtypes; D1 or D5 and D 2 , D 3 or D 4…”
BackgroundINTERHEMISPHERIC DIFFERENCES IN THE LOCALIZATION OF PSYCHOLOGICAL PROCESSES IN MAN
MILNER, B. (1971) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a070866 · Cited by 2,329 · cited 1×
“This visuospatial test of short term memory capacity (Owen et al. 1990) is based on the Corsi Block Tapping Task ( Milner 1971 ).”
MethodGrant, D. A., & Berg, E. (1948) · Journal of Experimental Psychology · doi:10.1037/h0059831 · Cited by 2,244
Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500
The two‐period cross‐over clinical trial.
Hills, M., & Armitage, P. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb05903.x · Cited by 1,395 · cited 1×
“Hills and Armitage 1979; Coull et al. 1995a, 1995b; Elliott et al. 1997).”
BackgroundD1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364 · cited 1×
“al. 1988, 1990; Sawaguchi and Goldman-Rakic 1991, 1994; Williams and Goldman-Rakic 1995).”
Planning and spatial working memory following frontal lobe lesions in man
Owen, A. M., Downes, J. J., Sahakian, B. J., Polkey, C. E., & Robbins, T. W. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90137-d · Cited by 1,245 · cited 4×
“Methylphenidate also impaired performance on the CANTAB battery version of the Tower of London task ( Owen et al. 1990 ), but only when it was familiar to subjects.”
BackgroundMethodInfluentialSelf-citation
Cited by
Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control
Cools, R., & D'Esposito, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.028 · Cited by 1,673
The cognitive functions of the caudate nucleus
Grahn, J. A., Parkinson, J. A., & Owen, A. M. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.004 · Cited by 940
“For example, Mehta et al. (1999) used the dopaminergic D2 receptor antagonist sulpiride (with the striatum as its presumed major site of action) to investigate the role of striatal dopamine in cognitive functioning.”
MethodCools, R. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.12.1136 · Cited by 906
“Psychopharmacological studies in healthy volunteers (Elliott et al., 1997; Mehta et al., 1999; Rogers et al., 1999) and studies on PD patients (Downes et al., 1989; Lange et al., 1992; Owen et al., 1992) have only provided ambiguous or conf licting results on the role of DA in ED shifting.”
BackgroundDopamine and Cognitive Control in Prefrontal Cortex
Ott, T., & Nieder, A. (2019) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2018.12.006 · Cited by 530
“Blocking D2Rs impairs shifting between response strategies in a variation of the WCST in which subjects were required to learn new visual discriminations based on different stimulus dimensions [129].”
BackgroundCognitive enhancing effects of modafinil in healthy volunteers
Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J., & Sahakian, B. J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1250-8 · Cited by 515
“Keywords Modafinil · Methylphenidate · Noradrenaline · Dopamine · Working memory · Attention”
BackgroundInfluentialSelf-citationFrank, M. J., & O'Reilly, R. C. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.3.497 · Cited by 472
“Whereas Mehta et al. (1999) interpreted their results as evidence for sulpiride simulating the cognitive profile of Parkinson's disease patients, we emphasize that blocking D 2 receptors in healthy participants may actually increase DA release during bursts.”
BackgroundResultFineberg, N. A., Chamberlain, S. R., Goudriaan, A. E., Stein, D. J., Vanderschuren, L. J. M. J., Gillan, C. M., Shekar, S., Gorwood, P. A. P. M., Voon, V., Morein-Zamir, S., et al. (2014) · CNS Spectrums · doi:10.1017/s1092852913000801 · Cited by 488
Self-citationChudasama, Y., & Robbins, T. W. (2006) · Biological Psychology · doi:10.1016/j.biopsycho.2006.01.005 · Cited by 484
Self-citationRobbins, T. W. (2007) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2007.2097 · Cited by 413
“(latency) measure (Mehta et al. 1999, 2004).”
BackgroundSelf-citationChemical neuromodulation of frontal-executive functions in humans and other animals
Robbins, T. W. (2000) · Experimental Brain Research · doi:10.1007/s002210000407 · Cited by 396
“…normal healthy volunteers, which showed that the drug generally simulated the pattern of cognitive deficits seen in Parkinson's disease, including impairments in certain forms of spatial working memory, attentional set-shifting and planning, though not visual recognition memory (Mehta et al. 1999).”
BackgroundSelf-citationPrefrontal Serotonin Depletion Affects Reversal Learning But Not Attentional Set Shifting
Clarke, H. F., Walker, S. C., Crofts, H. S., Dalley, J. W., Robbins, T. W., & Roberts, A. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3690-04.2005 · Cited by 358
“Consistent with a role for dopamine in set shifting, peripheral administration of the D2/D3 receptor antagonist sulpiride to human volunteers impaired extradimensional set shifting (Mehta et al., 1999), whereas an increase in dopaminergic activity induced by the catechol-Omethyltransferase inhibitor tolcapone is repor…”
BackgroundSelf-citationNitsche, M. A., Lampe, C., Antal, A., Liebetanz, D., Lang, N., Tergau, F., & Paulus, W. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04676.x · Cited by 339
“In healthy humans, the D2 antagonist SULP and the predominant D2 antagonist haloperidol (Kumari et al., 1997; Mehta et al., 1999) impaired learning.”
BackgroundInfluentialThe molecular genetics of cognition: dopamine, COMT and BDNF
Savitz, J., Solms, M., & Ramesar, R. (2006) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00163.x · Cited by 320
“Mehta et al. (1999) administered sulpiride, a D2 receptor antagonist, to healthy volunteers and found that the drug impaired spatial working memory, planning and attentional set-shifting.”
BackgroundProfile of Executive and Memory Function Associated with Amphetamine and Opiate Dependence
Ersche, K. D., Clark, L., London, M., Robbins, T. W., & Sahakian, B. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300889 · Cited by 311
“Previous research with this task indicates a pass rate around 80% in healthy volunteers, albeit in participants with a high level of education (Mehta et al, 1999).”
BackgroundSelf-citationNeurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease
Xu, Y., Yan, J., Zhou, P., Li, J., Gao, H., Xia, Y., & Wang, Q. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.02.002 · Cited by 301
“likely involved in the frontostriatal pathway (Mehta et al., 1999).”
BackgroundTurner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.008 · Cited by 301
Self-citationLukowski, A. F., Koss, M., Burden, M. J., Jonides, J., Nelson, C. A., Kaciroti, N., Jimenez, E., & Lozoff, B. (2010) · Nutritional Neuroscience · doi:10.1179/147683010x12611460763689 · Cited by 300
BRIGHT, P., JALDOW, E., & KOPELMAN, M. D. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702860131 · Cited by 293
“…given the extent to which the NART is applied in clinical, medicolegal and research settings (e.g., Cools et al., 2000; Isaac & Mayes, 1999; Langdon & Thomas, 1999; Lorch et al., 1999; Mavaddat et al., 2000; McKetin & Mattick, 1997; Mehta et al., 1999; Pantelis et al., 1999; Parkin et al., 1999).”
BackgroundResultRogers, R. D., Blackshaw, A. J., Middleton, H. C., Matthews, K., Hawtin, K., Crowley, C., Hopwood, A., Wallace, C., Deakin, J. F. W., Sahakian, B. J., et al. (1999) · Psychopharmacology · doi:10.1007/pl00005494 · Cited by 289
“More recently, acute doses of sulpiride, which selectively antagonises the DA D2 receptors mainly concentrated in the striatum, have been found to disrupt this form of shift learning in normal volunteers using the same three dimensional version of the ID/ED task as the present study, further highlighting the possible…”
MethodSelf-citationAtomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder
Chamberlain, S. R., del Campo, N., Dowson, J., Müller, U., Clark, L., Robbins, T. W., & Sahakian, B. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.003 · Cited by 288
Self-citationAalto, S., Brück, A., Laine, M., Någren, K., & Rinne, J. O. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2097-04.2005 · Cited by 284
“The effects of dopaminergic drugs on WM performance have been demonstrated in humans (Müller et al., 1998; Mehta et al., 1999), but it is unclear in which brain areas these drug effects take place.”
Molecular Imaging of the Dopaminergic System and its Association with Human Cognitive Function
Cropley, V. L., Fujita, M., Innis, R. B., & Nathan, P. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.004 · Cited by 283
Boosting focally-induced brain plasticity by dopamine
Kuo, M.-F., Paulus, W., & Nitsche, M. A. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm098 · Cited by 269
“…revealed that DA-enhancing agents facilitated working and long-term memory, whereas DA receptor blockers impaired it (Luciana et al. 1992; Kimberg et al. 1997; Luciana and Collins 1997; Muller et al. 1998; Mehta et al. 1999, 2001; Bartholomeusz et al. 2003; Knecht et al. 2004; Floel et al. 2005).”
BackgroundMethodInfluentialModafinil Improves Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia
Turner, D. C., Clark, L., Pomarol-Clotet, E., McKenna, P., Robbins, T. W., & Sahakian, B. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300457 · Cited by 258
Self-citationEarly Iron Deficiency Has Brain and Behavior Effects Consistent with Dopaminergic Dysfunction1–3
Lozoff, B. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.131169 · Cited by 260
Mehta, M. A., Goodyer, I. M., & Sahakian, B. J. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00221.x · Cited by 259
Self-citationThe role of the basal ganglia in learning and memory: Neuropsychological studies
Grahn, J. A., Parkinson, J. A., & Owen, A. M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.020 · Cited by 255
The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers
Murphy, F., Smith, K., Cowen, P., Robbins, T., & Sahakian, B. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1128-9 · Cited by 255
“For example, performance on the TOL planning task and the test of spatial working memory is significantly impaired by the dopamine D2 receptor antagonist sulpiride (Mehta et al. 1999) and improved by the indirect agonist methylphenidate (Elliott et al. 1997; Mehta et al. 2000).”
InfluentialSelf-citationBarr, R. S., Culhane, M. A., Jubelt, L. E., Mufti, R. S., Dyer, M. A., Weiss, A. P., Deckersbach, T., Kelly, J. F., Freudenreich, O., Goff, D. C., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301423 · Cited by 238
“The dopaminergic system is believed to modulate a range of cognitive processes, including response inhibition (Brozoski et al, 1979; Mehta et al, 1999; Cropley et al, 2006).”
BackgroundMehta, M. A., Swainson, R., Ogilvie, A. D., Sahakian, B., & Robbins, T. W. (2001) · Psychopharmacology · doi:10.1007/s002130100851 · Cited by 235
“In support of the latter hypothesis, we have recently shown that acute administration of sulpiride in healthy adults can simulate the profile of cognitive deficits seen in Parkinson’s disease (PD) ( Mehta et al. 1999 ), where the major neuropathology is degeneration of the mesencephalic nigrostriatal dopaminergic path…”
BackgroundSelf-citationMonte-Silva, K., Kuo, M.-F., Thirugnanasambandam, N., Liebetanz, D., Paulus, W., & Nitsche, M. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0728-09.2009 · Cited by 217
“Also D2-like receptors are involved in plasticity generation and cognitive processes (Otani et al., 1998; Mehta et al., 1999; Spencer and Murphy, 2000; Manahan-Vaughan and Kulla, 2003; Gibbs and D’Esposito, 2005; Nitsche et al., 2006).”
BackgroundDopaminergic control of cognitive flexibility in humans and animals
Klanker, M., Feenstra, M., & Denys, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00201 · Cited by 209
The Neural Circuitry of Executive Functions in Healthy Subjects and Parkinson's Disease
Leh, S. E., Petrides, M., & Strafella, A. P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.88 · Cited by 209
“Particular attention has been placed on dopaminergic modulation, as it can alleviate or worsen performance on working memory tasks (Fournet et al, 2000; Kimberg et al, 1997; Kimberg and D’Esposito, 2003; Kulisevsky et al, 1996; Mehta et al, 1999, 2001).”
BackgroundMehta, M. A., Manes, F. F., Magnolfi, G., Sahakian, B. J., & Robbins, T. W. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1899-2 · Cited by 196
“…has previously been shown to enhance planning performance, but only when the task was familiar to volunteers, or after defined training (Mehta et al. 1999, 2003), and methylphenidate (an indirect catecholamine agonist) has been shown to impair performance on a similar planning task…”
BackgroundMethodResultSelf-citationNeurogenetics and Pharmacology of Learning, Motivation, and Cognition
Frank, M. J., & Fossella, J. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.96 · Cited by 192
Barnett, J. H., Blackwell, A. D., Sahakian, B. J., & Robbins, T. W. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_5001 · Cited by 183
Self-citationPrefrontal cortex executive processes affected by stress in health and disease
Girotti, M., Adler, S. M., Bulin, S. E., Fucich, E. A., Paredes, D., & Morilak, D. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.004 · Cited by 176
Assessing cognitive function in clinical trials of schizophrenia
Barnett, J. H., Robbins, T. W., Leeson, V. C., Sahakian, B. J., Joyce, E. M., & Blackwell, A. D. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.012 · Cited by 174
“(Mehta et al., 1999)”
Self-citationEffects of modafinil on working memory processes in humans
M�ller, U., Steffenhagen, N., Regenthal, R., & Bublak, P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1926-3 · Cited by 170
“…by conventional psychostimulants like methylphenidate or amphetamine (Mattay et al. 2000) and impaired by noradrenaline and dopamine antagonists (Mehta et al. 1999); these findings are, however, not consistent across all studies, tasks and drugs (Ellis and Nathan 2001; Arnsten and Robbins 2002;…”
ResultHaloperidol Impairs Learning and Error-related Negativity in Humans
Zirnheld, P. J., Carroll, C. A., Kieffaber, P. D., O'Donnell, B. F., Shekhar, A., & Hetrick, W. P. (2004) · Journal of Cognitive Neuroscience · doi:10.1162/0898929041502779 · Cited by 170
“Haloperidol also worsens latent inhibition in humans (Williams et al., 1997), impairs working memory (Didriksen, 1995), and alters spatial recognition (Mehta et al., 1999).”
BackgroundInsights into the Role of Dopamine Receptor Systems in Learning and Memory
El-Ghundi, M., O'Dowd, B. F., & George, S. R. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.1.37 · Cited by 170
Dopaminergic mechanism of antidepressant action in depressed patients
Willner, P., Hale, A. S., & Argyropoulos, S. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.12.010 · Cited by 169
The Neuropsychology of Amphetamine and Opiate Dependence: Implications for Treatment
Ersche, K. D., & Sahakian, B. J. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9033-y · Cited by 166
“…improves with protracted drug abstinence (Kim et al. 2006), and may even reach normal level (Hoffman et al. 2006; Johanson et al. 2006; Toomey et al. 2003), is interesting, given the relationship between performance and D2 receptor availability (Mehta et al. 1999, 2004; Volkow et al. 1998).”
BackgroundSelf-citationTakahashi, H., Kato, M., Takano, H., Arakawa, R., Okumura, M., Otsuka, T., Kodaka, F., Hayashi, M., Okubo, Y., Ito, H., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3446-08.2008 · Cited by 165
“It was reported that blockade of D2 receptors in PFC did not impair working memory in nonhuman primate (Sawaguchi and Goldman-Rakic, 1994), but some human studies reported that systemic administration of D2 agonist or antagonist modulated cognitive functions that are subserved by the prefrontal cortex (McDowell et al.…”
BackgroundInfluentialFrangou, S., Donaldson, S., Hadjulis, M., Landau, S., & Goldstein, L. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.056 · Cited by 164
The many facets of motor learning and their relevance for Parkinson's disease
Marinelli, L., Quartarone, A., Hallett, M., Frazzitta, G., & Ghilardi, M. F. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2017.03.042 · Cited by 162
From arousal to cognition: the integrative position of the prefrontal cortex
Robbins, T. W. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)26030-5 · Cited by 166
Self-citationGIBBS, S. E. B., & D'ESPOSITO, M. (2005) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/cabn.5.2.212 · Cited by 145
Müller, U., Rowe, J. B., Rittman, T., Lewis, C., Robbins, T. W., & Sahakian, B. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.009 · Cited by 142
“Mehta et al., 1999; www.camcog.com Percentage correct, response latency.”
Self-citationAmphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans
Riccardi, P., Li, R., Ansari, M. S., Zald, D., Park, S., Dawant, B., Anderson, S., Doop, M., Woodward, N., Schoenberg, E., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300916 · Cited by 134
Reduced dopamine d1 receptor binding in the ventral striatum of cigarette smokers
Dagher, A., Bleicher, C., Aston, J. A. D., Gunn, R. N., Clarke, P. B. S., & Cumming, P. (2001) · Synapse · doi:10.1002/syn.1098 · Cited by 132
“This pattern can be replicated in normal subjects by administration of a dopamine D2 antagonist (Mehta et al., 1999) and PET studies suggest that the cognitive deficits in Parkinson’s disease are due to abnormal processing within the basal ganglia (Owen et al., 1998).”
BackgroundNeurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder
Turner, D. C., Blackwell, A. D., Dowson, J. H., McLean, A., & Sahakian, B. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1993-5 · Cited by 127
“One explanation for these results thus could be that the baseline performance of subjects is a crucial factor in determining the effects of methylphenidate on cognitive performance (Mehta et al. 1999b).”
BackgroundResultSelf-citationMuscarinic and nicotinic receptor modulation of object and spatial -back working memory in humans
GREEN, A., Ellis, K. A., ELLIS, J., Bartholomeusz, C., ILIC, S., Croft, R. J., LUANPHAN, K., & Nathan, P. J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.04.010 · Cited by 147
Human cognitive flexibility depends on dopamine D2 receptor signaling
van Holstein, M., Aarts, E., van der Schaaf, M. E., Geurts, D. E. M., Verkes, R. J., Franke, B., van Schouwenburg, M. R., & Cools, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2340-2 · Cited by 151
“1999), drug administration and candidate gene studies in healthy volunteers (Cools et al. 2007b; Mehta et al. 1999; Stelzel et al. 2010) as well as medication withdrawal studies in patients with Parkinson’s disease (Cools et al.”
BackgroundCognitive effects of the dopamine receptor agonist pergolide
Kimberg, D. Y., & D’Esposito, M. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(02)00317-2 · Cited by 141
“The interaction between the working memory capacity in a particular individual, and the effects of the dopaminergic agonist on cognitive performance has now been observed with two different dopaminergic agonists, across three studies[15,19,42] .”
BackgroundThe effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression
McLean, A., Rubinsztein, J. S., Robbins, T. W., & Sahakian, B. J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1586-8 · Cited by 125
“2001), whilst the D2 receptor antagonist, sulpiride, has been found to impair performance on tasks of spatial recognition, spatial working memory (sequence generation), planning and attentionalset shifting (Mehta et al. 1999).”
BackgroundResultInfluentialSelf-citationPartisanship, Voting, and the Dopamine D2 Receptor Gene
Dawes, C. T., & Fowler, J. H. (2009) · The Journal of Politics · doi:10.1017/s002238160909094x · Cited by 124
“Drugs stimulating D2 receptors have been shown to improve cognitive function (Berthier 2005; Kimberg, D’Esposito and Farah 1997; McDowell, Whyte, and D’Esposito 1998), while antagonist drugs impair them (Mehta et al. 1999).”
BackgroundPassetti, F., Dalley, J. W., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1227-7 · Cited by 121
“…(Simon 1981; Bubser and Schmidt 1990; Seamans et al. 1998), humans (Elliott et al. 1997; Luciana and Collins 1997; McDowell et al. 1998; Muller et al. 1998; Mehta et al. 1999) and non-human primates (Brozoski et al. 1979; Sawaguchi and Goldman-Rakic 1991; Roberts et al. 1994; Crofts et al. 2001).”
BackgroundSelf-citationCummings, D. M., Milnerwood, A. J., Dallérac, G. M., Waights, V., Brown, J. Y., Vatsavayai, S. C., Hirst, M. C., & Murphy, K. P. S. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl224 · Cited by 117
“In healthy participants, antagonism of D2 receptors induces cognitive deficits in learning (64) while verbal learning is improved by administration of levodopa (65).”
BackgroundModafinil affects mood, but not cognitive function, in healthy young volunteers
Randall, D. C., Shneerson, J. M., Plaha, K. K., & File, S. E. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.456 · Cited by 119
“, 2000), sulpiride (Mehta et al., 1999), as well as scopolamine (Robbins Figure 2.”
BackgroundInfluentialDodds, C. M., Muller, U., Clark, L., van Loon, A., Cools, R., & Robbins, T. W. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1153-08.2008 · Cited by 113
“Although previous studies that used a 400 mg dose found subtle effects of neurocognitive testing (Mehta et al., 1999), a recent PET study by Mehta et al.”
ResultSelf-citationvan Schouwenburg, M. R., Aarts, E., & Cools, R. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791293097 · Cited by 131
Carbon, M., Ma, Y., Barnes, A., DHAWAN, V. M., Chaly, T., Ghilardi, M. F., & Eidelberg, D. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.12.014 · Cited by 122
Csomor, P., Stadler, R. R., Feldon, J., Yee, B. K., Geyer, M. A., & Vollenweider, F. X. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301421 · Cited by 116
“Moreover, the D2 antagonist sulpiride impaired in some (Mehta et al, 1999, 2004) but not in all (Mehta et al, 2003, 2005) studies working memory performance, while the D2 receptor agonist bromocriptine enhanced working memory performance in healthy humans (Mehta et al, 2001).”
BackgroundSelective Effects of Acute Serotonin and Catecholamine Depletion on Memory in Healthy Women
Harrison, B. J., Olver, J. S., Norman, T. R., Burrows, G. D., Wesnes, K. A., & Nathan, P. J. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104040225 · Cited by 115
Kennedy, P. J., Clarke, G., O‘Neill, A., Groeger, J. A., Quigley, E. M. M., Shanahan, F., Cryan, J. F., & Dinan, T. G. (2014) · Psychological Medicine · doi:10.1017/s0033291713002171 · Cited by 106
“The outcome measures assessed were reversal learning (errors made on stages 2, 5, 7 and 9) and attentional fl exibility (errors made on stages 6 and 8), as described previously (Mehta et al. 1999; Rahman et al. 1999), and total errors (adjusted).”
Memory and frontal lobe functions; possible relations with dopamine D2 receptors in the hippocampus
Takahashi, H., Kato, M., Hayashi, M., Okubo, Y., Takano, A., Ito, H., & Suhara, T. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.11.008 · Cited by 101
The role of prefrontal catecholamines in attention and working memory
Clark, K. L., & Noudoost, B. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00033 · Cited by 100
Set-Shifting Ability and Schizophrenia: A Marker of Clinical Illness or an Intermediate Phenotype?
Ceaser, A. E., Goldberg, T. E., Egan, M. F., McMahon, R. P., Weinberger, D. R., & Gold, J. M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.009 · Cited by 100
Huijbregts, S. C. J., de Sonneville, L. M. J., van Spronsen, F. J., Licht, R., & Sergeant, J. A. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00040-4 · Cited by 105
“In view of the evidence that catecholamine modulation specifically influences manipulation functions of WM through ‘fronto-striatal loops’ [1,4,63,67,95], it could be argued that to improve the neuropsychological impairments of PKU, this pathway should be specifically targeted.”
BackgroundThe pharmacology of human working memory
Ellis, K. A., & Nathan, P. J. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002541 · Cited by 97
“Mehta et al. (1999), using a sample of 34 young healthy males, investigated the effect of the D # dopamine antagonist sulpiride on spatial working memory.”
MethodRoiser, J. P., McLean, A., Ogilvie, A. D., Blackwell, A. D., Bamber, D. J., Goodyer, I., Jones, P. B., & Sahakian, B. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300659 · Cited by 96
“The lack of an effect is somewhat surprising given that depressed patients perform poorly on the task (Elliott et al, 1997a, b), and other dopaminergic manipulations do produce detrimental performance on both this and other ‘frontal-executive’ tasks (Harmer et al, 2001; Mehta et al, 1999).”
BackgroundSelf-citationDopamine Receptors Differentially Enhance Rule Coding in Primate Prefrontal Cortex Neurons
Ott, T., Jacob, S. N., & Nieder, A. (2014) · Neuron · doi:10.1016/j.neuron.2014.11.012 · Cited by 98
“After blocking D2Rs in the PFC, rats were impaired in switching between different response strategies (Floresco et al., 2006), and blocking D2Rs impaired set-shifting in humans (Mehta et al., 1999).”
BackgroundRelative lack of cognitive effects of methylphenidate in elderly male volunteers
Clark, L., Aron, A. R., Dowson, J. H., Sahakian, B. J., Turner, D. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1457-3 · Cited by 97
“Similarly, administration of the dopamine D2 receptor antagonist sulpiride resulted in a dose dependent impairment at a sequence generation spatial working memory task (Mehta et al. 1999).”
BackgroundSelf-citationDopaminergic Enhancement of Cognitive Function
Mehta, M., & Riedel, W. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698891 · Cited by 91
Self-citationDopamine and the motivation of cognitive control
Cools, R., Froböse, M. I., Aarts, E., & Hofmans, L. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804281-6.00007-0 · Cited by 107
Müller, J., Dreisbach, G., Goschke, T., Hensch, T., Lesch, K., & Brocke, B. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05949.x · Cited by 90
“…dopamine ligands administered in vivo support the hypothesis of a dopaminergic modulation of the flexibility– stability balance: blocking D2 receptors caused an impairment of flexibility (Mehta et al., 1999, 2004b; Floresco et al., 2006), which fits well with the findings of Seamans et al. (2001).”
BackgroundStorbeck, J., & Maswood, R. (2015) · Cognition & Emotion · doi:10.1080/02699931.2015.1034091 · Cited by 109
Gibbs, S. E. B., & D'Esposito, M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0077-5 · Cited by 88
“Sulpiride, a nonspecific dopamine antagonist, caused behavioral deficits on tasks of spatial working memory (Mehta et al. 1999).”
BackgroundLateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease
Cheesman, A. L. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.055079 · Cited by 86
Patterns of attentional deficits and emotional bias in bipolar and major depressive disorder
Kerr, N., Scott, J., & Phillips, M. L. (2005) · British Journal of Clinical Psychology · doi:10.1348/014466505x57755 · Cited by 86
Wright, J. M., Dobosiewicz, M., & Clarke, P. B. S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2871-1 · Cited by 95
Linssen, A. M. W., Vuurman, E. F. P. M., Sambeth, A., & Riedel, W. J. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2605-9 · Cited by 84
“These include attention, response inhibition, planning and (working) memory (Cools and Robbins 2004; Luciana and Collins 1997; Luciana et al. 1992; Mehta et al. 1999; Pietrzak et al. 2006).”
BackgroundReeves, S., Grasby, P. M., Howard, R. J., Bantick, R. A., Asselin, M., & Mehta, M. A. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.034 · Cited by 88
Self-citationAmodeo, D. A., Jones, J. H., Sweeney, J. A., & Ragozzino, M. E. (2014) · Autism Research · doi:10.1002/aur.1395 · Cited by 83
Functional Significance of Central D1 Receptors in Cognition: Beyond Working Memory
Takahashi, H., Yamada, M., & Suhara, T. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.194 · Cited by 79
“It was reported that the systemic administration of the D2 agonist bromocriptine in human improved cognitive functions including working memory and executive functions (McDowell et al, 1998), and the administration of the D2 antagonist sulpiride impaired those functions (Mehta et al, 1999).”
BackgroundDopamine D2receptors mediate two-odor discrimination and reversal learning in C57BL/6 mice
Kruzich, P. J., & Grandy, D. K. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-12 · Cited by 91
“Administration of the D2R/D3R antagonist, sulpiride, impairs spatial reversal leaning in mice [20] and has also been shown to impair attention and the cognitive performances of healthy human volunteers [21].”
BackgroundMüller, J., Dreisbach, G., Brocke, B., Lesch, K., Strobel, A., & Goschke, T. (2006) · Brain Research · doi:10.1016/j.brainres.2006.11.002 · Cited by 86
“In attentional set-shifting tasks, application of dopamine antagonists impaired flexibility in humans (Mehta et al., 2004, 1999) and rats (Floresco et al., 2006).”
BackgroundSerotonergic and dopaminergic modulation of attentional processes
Boulougouris, V., & Tsaltas, E. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00925-4 · Cited by 82
Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats
Nikiforuk, A., Gołembiowska, K., & Popik, P. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.08.001 · Cited by 77
“For instance, a deficit in attentional-set shifting was observed in healthy humans after administration of the DA D2 receptor antagonist sulpiride (Mehta et al., 1999), and DA depletion impaired fronto-striatal functional connectivity during the set-shifting task (Nagano-Saito et al.”
BackgroundLack of effects of guanfacine on executive and memory functions in healthy male volunteers
Müller, U., Clark, L., Lam, M. L., Moore, R. M., Murphy, C. L., Richmond, N. K., Sandhu, R. S., Wilkins, I. A., Menon, D. K., Sahakian, B. J., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0078-4 · Cited by 73
“PRM Pattern Recognition Memory: a computerised dual-choice test of abstract visual pattern recognition Mehta et al. 1999 Percentage correct, response latency”
Self-citationGijsman, H. J., Scarnà, A., Harmer, C. J., Sarah, M., Odontiadis, J., Cowen, P. J., & Goodwin, G. M. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0970-5 · Cited by 81
Ko, J. H., Ptito, A., Monchi, O., Cho, S. S., van Eimeren, T., Pellecchia, G., Ballanger, B., Rusjan, P., Houle, S., & Strafella, A. P. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.02.031 · Cited by 81
“Since it is known that dopaminergic modulation can alleviate or worsen the performance on working memory tasks (Fournet et al., 2000; Kimberg et al., 1997; Kimberg and D’Esposito, 2003; Kulisevsky et al., 1996; Mehta et al.,1999, 2001), this neurotransmitter has received particular attention.”
Compensatory neural mechanisms in cognitively unimpaired P arkinson disease
Poston, K. L., YorkWilliams, S. L., Zhang, K., Cai, W., Everling, D., Tayim, F. M., Llanes, S., & Menon, V. (2015) · Annals of Neurology · doi:10.1002/ana.24585 · Cited by 81
“Dopamine is critical for normal working memory,(15,16) and administration of dopamine-receptor blocking medications to normal adults leads to deficits in working memory ability.(17) Functional magnetic resonance imaging (fMRI) of healthy individuals has identified a frontostriatal network, involving the caudate, putam…”
BackgroundMillan, M. J., Buccafusco, J. J., Loiseau, F., Watson, D. J. G., Decamp, E., Fone, K. C. F., Thomasson-Perret, N., Hill, M., Mocaer, E., & Schneider, J. S. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000775 · Cited by 71
“2009) and disrupted an EDS-ASST in healthy humans (Mehta et al. 1999), while raclopride perturbed reversal learning in monkeys (Lee et al.”
BackgroundHettinger, J. A., Liu, X., Hudson, M. L., Lee, A., Cohen, I. L., Michaelis, R. C., Schwartz, C. E., Lewis, S. M., & Holden, J. J. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-19 · Cited by 68
“The dopamine D2 receptor is involved in the DAergic modulation of executive functions [23], reversal learning [24] and emotional processing [25].”
BackgroundDodds, C. M., Clark, L., Dove, A., Regenthal, R., Baumann, F., Bullmore, E., Robbins, T. W., & Müller, U. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1634-0 · Cited by 66
“Dose selection was based on previous, similar studies showing behavioural effects at similar (and lower) doses using the same drugs in healthy volunteers (Mehta et al. 1999).”
BackgroundSelf-citationSulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions
Passetti, F., Levita, L., & Robbins, T. W. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00229-2 · Cited by 75
Self-citationMonte-Silva, K. K., Ruge, D., Teo, J., Paulus, W., Rothwell, J. C., & Nitsche, M. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.100 · Cited by 70
Mehta, M. A., Hinton, E. C., Montgomery, A. J., Bantick, R. A., & Grasby, P. M. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048889 · Cited by 63
Self-citation
Metadata
- Authors
- Mehta, M. A., Sahakian, B. J., McKenna, P. J., & Robbins, T. W.
- Affiliations
- University of Cambridge (GB)
- Fulbourn Hospital (GB)
- Venue
- Psychopharmacology
- Published
- 1999-09-24
- Volume
- 146
- Issue
- 2
- Pages
- 162-174
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2003119385
- Cited by
- 223
- References
- 49
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 8 · 2021: 1 · 2020: 3 · 2019: 8 · 2018: 1 · 2017: 6 · 2016: 1 · 2015: 7 · 2014: 8 · 2013: 11 · 2012: 8
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- sulpiride, Parkinson's disease, cognitive impairment, dopamine D2 receptor antagonists, prefrontal cortex, spatial working memory, planning, set-shifting, sustained attention, frontal lobe damage, dose-dependent effects, healthy volunteers
- MeSH terms
- Adult, Affect, Association Learning, Attention, Cognition Disorders, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Learning, Male, Neuropsychological Tests, Pattern Recognition, Visual, Psychomotor Performance, Surveys and Questionnaires, Space Perception, Sulpiride, Antipsychotic Agents, Dopamine Antagonists, Cross-Over Studies, Parkinsonian Disorders, Dopamine D2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.